课题基金 / 基金详情

Breakthrough in the mechanism of adenoviral gene delivery and new developments to apply the achievement in a clinical setting

Breakthrough in the mechanism of adenoviral gene delivery and new developments to apply the achievement in a clinical setting
腺病毒基因传递机制的突破及临床应用新进展
批准号:
21791298
负责人:
EGAMI Takuya
金额:
$2.75万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2010

项目摘要

项目成果

EGAMI Takuya的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We revealed that the efficacy of adenoviral therapy was enhanced with combination chemotherapy or radiation. We found that the efficiency of adenoviral therapy in radiation resistant cancer cells was lower than that in radiation sensitive cells, while the efficiency of adenoviral therapy in chemoresistant cancer cells was lower than that in chemosensitive cells. We also revealed that fibroblasts which constitute stroma weaken the efficacy of adenoviral therapy. Furthermore we figured out these mechanisms and identified the molecules responsible for the mechanisms. These data suggest that there are possibilities in adenoviral therapy for individual by evaluating the molecules responsible for adenoviral infection and uptake with respect to each case.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Combination with low-dose gemcitabine andhTERT-promoter-dependent conditionally replicative adenovirus enhances cytotoxicity through their crosstalk mechanisms in pancreatic cancer
与低剂量吉西他滨和 hTERT 启动子依赖性条件复制腺病毒联合使用,通过其串扰机制增强胰腺癌中的细胞毒性
DOI: --
发表时间: 2010
期刊: Cancer Lett
影响因子: 9.7
作者: [Onimaru M, Ohuchida K, Nagai E,Mizumoto K, Egami T, Tanaka M]
通讯作者: Tanaka M
DOI: 10.1111/j.1349-7006.2009.01101.x
发表时间: 2009-04-01
期刊: CANCER SCIENCE
影响因子: 5.7
作者: [Egami, Takuya, Ohuchida, Kenoki, Tanaka, Masao]
通讯作者: Tanaka, Masao
膵癌の線維芽細胞によるアデノウイルス導入効率の阻害効果
对胰腺癌成纤维细胞腺病毒转导效率的抑制作用
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [安井隆晴, 他]
通讯作者:
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [鬼丸学, 他]
通讯作者:
12
    Development of novel treatment for pancreatic cancer to break through the fibrotic barrier by combining pancreatic stellate cell inhibitors with nanoparticles
    • 批准号:
      20K07661
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2020
    • 负责人:
      EGAMI Takuya
    • 依托单位:
    The role of autophagy in perineural infiltration of pancreatic cancer
    • 批准号:
      16K10597
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2016
    • 负责人:
      EGAMI Takuya
    • 依托单位:
    The improvement of therapy-resistance with modified new virus and application to the treatment in pancreatic cancer
    • 批准号:
      25462119
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.24万
    • 财政年份:
      2013
    • 负责人:
      EGAMI Takuya
    • 依托单位:
    Development of new therapeutic artificial virus with the ability of escape from endocytosis
    • 批准号:
      23791543
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.75万
    • 财政年份:
      2011
    • 负责人:
      EGAMI Takuya
    • 依托单位:
    海外基金